Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Sarcoma 1Lymphoid 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Carcinoma, Hepatocellular 2Stomach Neoplasms 1Rhabdomyosarcoma 1Recurrence 1Pancreatic Ductal Adenocarcinoma 1Pancreatic Diseases 1Neuroblastoma 1Neoplasm Metastasis 1Medulloblastoma 1Liver Neoplasms 1Hepatoblastoma 1Hematologic Neoplasms 1Glioma 1Glioblastoma 1Fibrosis 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma 1Breast Neoplasms 1Basal Cell Nevus Syndrome 1Astrocytoma 1

Interventions

Carboplatin 4sargramostim 3Temozolomide 3Filgrastim 3tovorafenib 2regorafenib 2Thiotepa 2Sirolimus 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Oxaliplatin 2Nivolumab 2Melphalan 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Busulfan 2vocimagene amiretrorepvec 1trastuzumab deruxtecan 1sonidegib 1pembrolizumab 1ixabepilone 1etoposide phosphate 1entinostat 1cediranib 1aflibercept 1Thalidomide 1Tamoxifen 1Stem Cell Transplantation 1Radiotherapy, Intensity-Modulated 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Astrocytoma × sonidegib × Gastrointestinal × Clear all
NCT01125800 2017-03-20

A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB

Novartis

Phase 1/2 Completed
76 enrolled 18 charts
CNSGastrointestinalSarcoma

Astrocytoma, Glioma, Medulloblastoma, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡